Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Nov 17: Astellas and Pfizer won FDA approval Friday for Xtandi, an androgen receptor signaling inhibitor, to treat nonmetastatic castration-sensitive prostate cancer (nmCSPC)
Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, Melvin DL, Egan JM: Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes
Its worth noting that cardiovascular mortality over two years was 50% to 70% higher in patients using sulfonylureas compared to those on metformin, according to research
Ggotek A, Skrzydlewska E
US$ 26.90
US$ 26.81
US$ 25.22
US$ 29.05
:max_bytes(150000):strip_icc()/VWH-GettyImages-2190414326-0d878e64bbf84b179058fbdc220cf21e.jpg)
US$ 25.45
